Clinical trial
Metabolic Profiling of Esketamine Treatment in Major Depressive Disorder
NCT07002684 is registered in ClinicalTrials.gov with University of Zagreb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolic Profiling of Esketamine Treatment in Major Depressive Disorder
- Lead sponsor
- University of Zagreb
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.